ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$100.73
*  
3.52
3.62%
Get ALNY Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALNY Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog
1/22/2014 1:01:01 PM - Zacks.com


Orphan Drug Status for Alexion's Solaris - Analyst Blog
1/22/2014 12:00:01 PM - Zacks.com


Prospects Bright at Alexion Pharma - Analyst Blog
1/16/2014 11:40:01 AM - Zacks.com


Biotech Stock Roundup: Intercept Pharma Grabs the Limelight - Analyst Blog
1/15/2014 9:31:01 AM - Zacks.com


Company news for January 14, 2014 - Corporate Summary
1/14/2014 10:06:01 AM - Zacks.com


Alnylam Pharmaceuticals (ALNY) Soars: Stock Up 40.9% - Tale of the Tape
1/14/2014 8:51:01 AM - Zacks.com


Alnylam Pharmaceuticals, Inc. (ALNY) Enters Overbought Territory - Tale of the Tape
1/14/2014 7:12:01 AM - Zacks.com


Cramer's Lightning Round - Whole Foods Is Not Going Up Right Away (1/13/14)
1/14/2014 6:03:00 AM - Seeking Alpha


Pipeline Update at Alnylam - Analyst Blog
1/13/2014 6:20:01 PM - Zacks.com


Mid-Afternoon Market Update: Markets Dip Despite Large Amount of M&A
1/13/2014 4:14:04 PM - Benzinga


Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam Shares Spike Higher
1/13/2014 12:52:58 PM - Benzinga


European Shares Rise on Easier Basel Regulations
1/13/2014 12:46:37 PM - MT Newswires


Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook
1/13/2014 10:39:13 AM - Benzinga


Alnylam Pharmaceuticals, Inc. (ALNY): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/9/2014 7:00:01 AM - Zacks.com


Tekmira's Transition Worth Watching
12/27/2013 9:40:00 AM - Seeking Alpha


Pipeline Progress at Alnylam - Analyst Blog
12/23/2013 4:18:30 PM - Zacks.com


Alnylam: Bold Moves Toward A New Class Of Medicine
12/11/2013 6:33:00 PM - Seeking Alpha


Alnylam Earns Milestone Payment - Analyst Blog
11/26/2013 5:52:01 PM - Zacks.com


Biotech Stock Roundup: Vanda Soars, Sarepta Slumps - Analyst Blog
11/20/2013 11:07:51 AM - Zacks.com


Sector Update: Healthcare
11/18/2013 8:47:21 AM - MT Newswires


Sector Update: Healthcare Shares Mixed; CareFusion Agrees to Acquire General Electric
11/18/2013 8:42:45 AM - MT Newswires


Sector Update: Healthcare
11/18/2013 8:35:03 AM - MT Newswires


Healthcare Stocks Sliding into Close; Alynylam Pharma Sinks After Net Loss is Larger than Forecast
11/7/2013 3:57:41 PM - MT Newswires


Sector Update: Healthcare
11/7/2013 3:56:11 PM - MT Newswires


Wider-than-Expected Q3 Loss at Alnylam - Analyst Blog
11/7/2013 10:00:01 AM - Zacks.com